Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
Aadi Bioscience (NASDAQ: AADI) has announced its upcoming participation in the TD Cowen 45th Annual Healthcare Conference in Boston, MA.
Rhea-AI Summary
Aadi Bioscience (NASDAQ: AADI) has announced its upcoming participation in the TD Cowen 45th Annual Healthcare Conference in Boston, MA. The conference is scheduled for March 3-5, 2025, where CEO Dave Lennon, PhD, will deliver a company overview presentation on Monday, March 3, 2025, from 9:50 – 10:20 AM ET.
The presentation will be accessible through a live webcast on the company's IR website pages, with replay availability for approximately 30 days after the event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AADI
The recorded move for AADI in the trading session of this news was -2.51%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation will be webcast live on the IR pages of the Aadi Bioscience website and will be available for replay for approximately 30 days following the investor event.
About Aadi Bioscience
Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat cancers. More information on the Company is available on the Aadi website at www.aadibio.com and connect with us on LinkedIn.
Contact:
IR@aadibio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-at-the-td-cowen-45th-annual-healthcare-conference-302383012.html
SOURCE Aadi Bioscience
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
